Susquehanna Fundamental Investments LLC Purchases New Position in Huron Consulting Group Inc. (NASDAQ:HURN)

Susquehanna Fundamental Investments LLC purchased a new position in Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 14,304 shares of the business services provider's stock, valued at approximately $1,777,000. Susquehanna Fundamental Investments LLC owned about 0.08% of Huron Consulting Group as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HURN. Two Sigma Securities LLC purchased a new position in Huron Consulting Group during the 4th quarter valued at $209,000. Price T Rowe Associates Inc. MD increased its position in shares of Huron Consulting Group by 3.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 19,264 shares of the business services provider's stock valued at $2,394,000 after purchasing an additional 596 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Huron Consulting Group by 27.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after acquiring an additional 122 shares during the period. Teachers Retirement System of The State of Kentucky increased its stake in Huron Consulting Group by 19.6% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 14,296 shares of the business services provider's stock worth $1,776,000 after buying an additional 2,342 shares in the last quarter. Finally, MetLife Investment Management LLC grew its position in shares of Huron Consulting Group by 6.9% during the fourth quarter. MetLife Investment Management LLC now owns 10,617 shares of the business services provider's stock worth $1,319,000 after purchasing an additional 682 shares in the last quarter. 93.90% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Barrington Research boosted their price target on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a research note on Monday. Wedbush boosted their price objective on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research note on Wednesday, March 26th. StockNews.com lowered Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday. Benchmark reaffirmed a "buy" rating and set a $165.00 target price on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Finally, Truist Financial raised their price target on Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a report on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Huron Consulting Group has a consensus rating of "Moderate Buy" and an average target price of $170.75.

Insider Buying and Selling at Huron Consulting Group

In other news, CEO C. Mark Hussey sold 27,672 shares of the company's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $145.91, for a total value of $4,037,621.52. Following the transaction, the chief executive officer now directly owns 81,118 shares of the company's stock, valued at approximately $11,835,927.38. This represents a 25.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director James H. Roth sold 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $126.03, for a total value of $252,060.00. Following the completion of the transaction, the director now directly owns 48,534 shares in the company, valued at $6,116,740.02. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 78,239 shares of company stock worth $11,420,861. 2.15% of the stock is owned by company insiders.

Huron Consulting Group Trading Down 0.3 %

Shares of NASDAQ HURN traded down $0.41 during trading on Tuesday, hitting $147.91. 17,710 shares of the company were exchanged, compared to its average volume of 147,785. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market capitalization of $2.55 billion, a PE ratio of 32.15 and a beta of 0.23. The company has a fifty day moving average price of $143.10 and a 200-day moving average price of $130.24. Huron Consulting Group Inc. has a 12-month low of $84.87 and a 12-month high of $153.85.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last announced its earnings results on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.52. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The business had revenue of $404.14 million for the quarter, compared to analysts' expectations of $389.27 million. During the same period in the previous year, the company posted $1.23 EPS. The company's quarterly revenue was up 11.2% on a year-over-year basis. As a group, equities research analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.